Cleared Traditional

K252373 - BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology (FDA 510(k) Clearance)

Also includes:
BioFlo PICC with ENDEXO Technology and PASV Valve Technology BioFlo PICC with ENDEXO Technology BioFlo Midline Catheter Xcela Power Injectable PICC Xcela PICC with PASV Valve Technology Xcela Hybrid PICC with PASV Valve Technology
Dec 2025
Decision
139d
Days
Class 2
Risk

K252373 is an FDA 510(k) clearance for the BioFlo Hybrid PICC with ENDEXO Technology and PASV Valve Technology. This device is classified as a Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days (Class II - Special Controls, product code LJS).

Submitted by Spectrum Vascular (White Plains, US). The FDA issued a Cleared decision on December 16, 2025, 139 days after receiving the submission on July 30, 2025.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5970.

Submission Details

510(k) Number K252373 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 30, 2025
Decision Date December 16, 2025
Days to Decision 139 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code LJS - Catheter, Intravascular, Therapeutic, Long-term Greater Than 30 Days
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5970